Nevada has been relatively active in the most recent legislative term on healthcare price transparency, costs, and markets. Nevadas primary effort in healthcare transparency and cost containment in 2017 was the Nevada Care Plan, which would have allowed anyone without health insurance buy into the states Medicaid program. Because of Medicaids low reimbursement rates for doctors and other health-care providers, it may have provided an economical alternative to private insurance, though at the cost of narrower provider options. The bill creating this new Medicaid buy-in cleared the legislature, but was vetoed by Republican Governor Brian Sandoval.Nevada also gained widespread attention as the first state to target medicines for a specific ailment, passing SB 539 which requires more transparency from drug makers over their pricing of diabetes medicines. The pharmaceutical industry pushed back with a lawsuit claiming the transparency law is unprecedented and unconstitutional, because it interferes with well-established patent law by robbing drug makers of their right to protect trade secrets. The case is outstanding in Nevada District Court.
The State Database
The Source tracks state activities impacting healthcare price and competition in both legislation and litigation in a searchable database to help stakeholders at the state level understand their legal and regulatory environment as they make efforts to improve access, quality, and efficiency, and reduce costs in healthcare.
LEGISLATION: The Database of State Laws Impacting Healthcare Cost and Quality (SLIHCQ), created by The Source on Healthcare Price & Competition and Catalyst for Payment Reform, catalogues state legislation governing price transparency, provider market power, provider payment, provider networks, and benefit design. The database also includes pharmaceutical legislation beginning in the 2017-2018 legislative session. *Note: Current legislative session bill updates are ongoing. Check back weekly for updates.
LITIGATION: The Source tracks major litigation and antitrust enforcement action by federal entities (FTC or DOJ), state attorney generals, and private parties in the main provider and insurer markets, particularly legal challenges of healthcare consolidation and anticompetitive contract provisions. Additionally, the database contains major pharmaceutical cases including legislation challenges and significant appellate cases.
Search the database across all jurisdictions on the State Overview page, or view and filter existing legislation or litigation on individual state pages. The database allows customized search and filter by keyword, status, and/or key issue category. *Multiple filter/selections enabled. Click here for User Guide.
LEGISLATIVE CALENDARNevada’s current legislative session runs from 2/4/2019 – 6/3/2019.
2018-2019 BUDGETNevada operates on a biennial budget cycle. Nevada’s fiscal year begins on July 1 and ends on June 30. Nevada enacted its 2018-2019 Budget during the regular legislative session. To view Nevada’s Department of Health and Human Services spending plan, click here.
REGULATION & ENFORCEMENT
- Nevada was one of 16 states to file an amicus brief supporting the FTC’s winning position in the Ninth Circuit appeal of St. Luke’s Health Care Sys. v. FTC, No. 14-35173 (March 7, 2014), decided February 10, 2015. The States’ brief stated that the acceleration of health care costs due to the growth of large health care provider systems had become a matter of grave concern for the states.